STAR — Strides Pharma Science Share Price
0.000.00%
Last trade - 00:00- IN₹80.57bn
- IN₹103.59bn
- IN₹36.88bn
- 64
- 17
- 97
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.62 | ||
| PEG Ratio (f) | 0.31 | ||
| EPS Growth (f) | 237.92% | ||
| Dividend Yield (f) | 0.41% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.92 | ||
| Price to Tang. Book | 8.05 | ||
| Price to Free Cashflow | 26.48 | ||
| Price to Sales | 2.04 | ||
| EV to EBITDA | 21.55 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.78% | ||
| Return on Equity | -6.95% | ||
| Operating Margin | 6.3% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 21,783.74 | 27,519.71 | 33,158.7 | 30,702.5 | 36,883.87 | 41,158.5 | 44,596.5 | 5.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -22.58 | +67.91 | +111.34 | n/a | n/a | n/a | +237.92 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Directors
- Deepak Vaidya NEC (76)
- R. Ananthanarayanan CEO
- Badree Komandur CFO
- Subroto Banerjee CEX
- Manjula Ramamurthy CCO
- Arun Kumar EDR
- Homi Khusrokhan IND (74)
- Sangita Reddy IND (59)
- Kausalya Santhanam IND
- Bharat Shah NID (74)
- Srinivasan Sridhar NID (64)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 28th, 1990
- Public Since
- February 3rd, 2000
- No. of Shareholders
- 120,916
- No. of Employees
- 2,850
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 91,899,714
- Address
- Strides House, BANGALORE, 560076
- Web
- https://www.strides.com/
- Phone
- +91 8067840000
- Auditors
- BSR & Co. LLP
Upcoming Events for STAR
Q1 2025 Strides Pharma Science Ltd Earnings Release
Strides Pharma Science Ltd Annual Shareholders Meeting
Q2 2025 Strides Pharma Science Ltd Earnings Release
Similar to STAR
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Strides Pharma Science share price?
As of Today at 19:20 UTC, shares in Strides Pharma Science are trading at IN₹876.70. This share price information is delayed by 15 minutes.
How has the Strides Pharma Science share price performed this year?
Shares in Strides Pharma Science last closed at IN₹876.70 and the price had moved by +159.88% over the past 365 days. In terms of relative price strength the Strides Pharma Science share price has outperformed the S&P BSE 100 Index by +99.63% over the past year.
What are the analyst and broker recommendations for Strides Pharma Science?
The overall consensus recommendation for Strides Pharma Science is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Strides Pharma Science dividend yield?
The Strides Pharma Science dividend yield is 0.17% based on the trailing twelve month period.
Does Strides Pharma Science pay a dividend?
Last year, Strides Pharma Science paid a total dividend of IN₹1.50, and it currently has a trailing dividend yield of 0.17%. We do not have any data on when Strides Pharma Science is to next pay dividends.
When does Strides Pharma Science next pay dividends?
We do not have data on when Strides Pharma Science is to next pay dividends. The historic dividend yield on Strides Pharma Science shares is currently 0.17%.
How do I buy Strides Pharma Science shares?
To buy shares in Strides Pharma Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Strides Pharma Science?
As of the previous close price of IN₹876.70, shares in Strides Pharma Science had a market capitalisation of IN₹80.57bn.
Where are Strides Pharma Science shares listed?
Here are the trading details for Strides Pharma Science:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: STAR
What kind of share is Strides Pharma Science?
Based on an overall assessment of its quality, value and momentum Strides Pharma Science is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Strides Pharma Science share price forecast for 2024?
The analyst consensus target price for shares in Strides Pharma Science is IN₹837.50. That is 4.47% below the last closing price of IN₹876.70.
Analysts covering Strides Pharma Science currently have a consensus Earnings Per Share (EPS) forecast of IN₹12.00 for the next financial year.
What is the trend in the Strides Pharma Science share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Strides Pharma Science. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +45.76%.
As of the last closing price of IN₹876.70, shares in Strides Pharma Science were trading +46.31% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Strides Pharma Science PE Ratio?
The Strides Pharma Science PE ratio based on its reported earnings over the past 12 months is 21.62. The shares last closed at IN₹876.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Strides Pharma Science?
Strides Pharma Science's management team is headed by:
- Deepak Vaidya - NEC
- R. Ananthanarayanan - CEO
- Badree Komandur - CFO
- Subroto Banerjee - CEX
- Manjula Ramamurthy - CCO
- Arun Kumar - EDR
- Homi Khusrokhan - IND
- Sangita Reddy - IND
- Kausalya Santhanam - IND
- Bharat Shah - NID
- Srinivasan Sridhar - NID